As you may be aware a new CFTR Modulator called Trikafta, also known as triple-combination therapy, was approved in June 2021 for use in Canada.
Our clinic is working diligently to access this medication for our 375+ patients who are eligible. While we have created an FAQS list available by email bounce back at CFTRModulatorInfo@unityhealth.to we anticipate you may have further questions so have organized a Trikafta Update: Webinar/ Q&A in the coming weeks.
We ask that you forward any questions in advance to CFTRModulatorInfo@unityhealth.to so we may prepare for the session.
Event: Trikafta Update: Webinar/ Q&A
Date: Wednesday Dec 15, 2021
Time: 7-8:30pm (1hr presentation with an additional 30 min for further questions).
ZOOM: Please email CFTRModulatorInfo@unityhealth.to to receive an invitation for this event.
Agenda for Trikafta Update Webinar:
- Review who has access to Trikafta at the current time.
- How is Trikafta accessed through public funding.
- What process is SMH using to start patients on Trikafta.
NB: This webinar will be recorded and available on our YouTube Channel in the future.
Looking forward to seeing you there.
The Toronto Adult CF Clinic